Global Medical Reit INC 8-K filings

Chiron Real Estate Inc. announced its second quarter 2026 financial results, detailing progress in portfolio repositioning through SHOP acquisitions and legacy asset sales, alongside leadership team expansions.

Chiron Real Estate Inc. announced the appointment of Matthew Whitlock as Chief Investment Officer and the transition of Alfonzo Leon to Strategic Advisor, effective August 3, 2026.

Chiron Real Estate Inc. has announced key executive appointments and entered into new employment agreements with its senior leadership team, effective July 16, 2026.

Chiron Real Estate Inc. has updated its investor presentation, detailing strategic portfolio repositioning, capital allocation, and recent transactions aimed at delivering higher returns on invested capital.

Chiron Real Estate Inc. has completed the sale of a seven-property inpatient rehabilitation hospital portfolio for $217 million, retaining a 15% interest in the acquiring joint venture.

Chiron Real Estate Inc. announced the acquisition of two senior housing communities for $248.9 million and the successful private placement of Series C Convertible Preferred Stock raising $100 million.

Chiron Real Estate Inc. has appointed industry veteran Charles Fitzgerald to its Board of Directors and declared its second quarter 2026 preferred stock dividends.

Chiron Real Estate is repositioning as a growth-oriented healthcare REIT, acquiring $425 million in senior housing assets and securing $100 million in convertible preferred equity.

Chiron Real Estate Inc. and its operating partnership entered into a Master Note and Guaranty Agreement for an uncommitted senior note facility of up to $150 million with NYL Investors LLC.

Chiron Real Estate Inc. announced a net loss for Q4 2025 despite increased FFO and Same-Property Cash NOI, alongside a corporate rebrand, strategic objectives, and a shift to monthly common dividends.

Global Medical REIT Inc. announced that director Henry Cole will step down at the 2026 Annual Meeting of Stockholders, with no disagreement cited.

Global Medical REIT Inc. announced that director Ronald Marston will retire effective at the company's 2026 Annual Meeting of Stockholders.

Global Medical REIT Inc. announced the pricing of an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock at $25.00 per share.

Global Medical REIT Inc. reported a net loss of $6.0 million for Q3 2025, or $0.45 per diluted share, a significant decline from net income in the prior year, alongside increased debt and an impairment charge.

Global Medical REIT Inc. announced a net loss for Q3 2025 due to an impairment charge, but reported increased FFO and AFFO, and successfully extended its credit facility maturities.

Global Medical REIT Inc. announced a new credit facility, extending maturities for its $400 million revolver and $350 million term loan, while hedging interest rate risk.

Global Medical REIT Inc. has completed a one-for-five reverse stock split, reducing outstanding shares and adjusting authorized capital.

Global Medical REIT reports improved Q2 2025 financial results, appoints Mark Decker, Jr. as CEO, and reaffirms full-year AFFO guidance.

Global Medical REIT Inc. announced the appointment of Mark O. Decker, Jr. as its new Chief Executive Officer and President, effective June 23, 2025, succeeding Jeffrey M. Busch who will transition to non-executive Chairman of the Board.

Global Medical REIT Inc. announced a reduction in its quarterly common stock dividend from $0.21 to $0.15 per share, aiming to strengthen its balance sheet, reduce leverage, and provide flexibility for future growth opportunities.

Global Medical REIT held its 2025 annual meeting of stockholders, electing directors, approving executive compensation, and ratifying the appointment of Deloitte & Touche LLP as its independent accounting firm.

Global Medical REIT (GMRE) reports its Q1 2025 financial results, highlighting the completion of a $69.6 million medical portfolio acquisition and reaffirming its full-year AFFO guidance.

Global Medical REIT reports its Q4 and full year 2024 financial results, highlighting acquisitions, a joint venture with Heitman, and provides AFFO guidance for 2025.

Global Medical REIT has announced that CEO Jeffrey Busch will transition out of his role, with a successor to be named by June 30, 2025, while he is expected to remain on the board as non-executive chairman.

Global Medical REIT provided an update on its recent acquisitions, dispositions, lease activity, and financial position in a new investor presentation.

Global Medical REIT reported its third quarter 2024 financial results, including a net income of $1.8 million, and completed $80.3 million in acquisitions of single-tenant medical real estate.

Global Medical REIT has successfully re-leased its Beaumont, Texas facility to CHRISTUS Health for 15 years following the bankruptcy of the previous tenant, Steward Health Care.

Global Medical REIT announced its second quarter 2024 financial results, marked by a net loss but also highlighted by strategic acquisitions and dispositions.

Global Medical REIT Inc. has amended its previous 8-K filing to announce that future advisory votes on executive compensation will be held annually, following the results of the 2024 annual meeting.

Global Medical REIT updated its investor presentation on June 3, 2024, showcasing its healthcare real estate portfolio and strategic approach.